Heart health
UltraSight has raised US$24m to expand its AI-guided cardiac ultrasound platform across US hospitals and develop intensive care and circulatory support workflows. The Israeli company said the Series B2 financing will support wider adoption of its Echosystem platform in the US and the development of additional tools for clinical settings where rapid imaging can directly [...]
Eye scans may reveal retinal changes linked to atrial fibrillation about four years before hospital diagnosis, a study of more than 90,000 people found. Atrial fibrillation is the most common heart rhythm disorder and affects more than 1.5m people in the UK. It raises the risk of stroke, heart failure and death. Because [...]
A University of Bristol University spinout has launched with more than £700,000 of pre-seed funding to develop a blood test for detecting and monitoring microvascular disease. Dimension Technologies' novel blood test aims identify biochemical signs of disease in the microvasculature, the network of microscopic blood vessels that delivers oxygen and nutrients throughout the body. Damage [...]
Implicity has raised €35m to expand its cardiac monitoring platform internationally, with a focus on the US and further development of its AI capabilities. The Paris-based health tech company plans to use the funding to scale its commercial operations and develop its next generation of heart failure prediction algorithms. Implicity specialises in remote cardiac monitoring [...]
Elucid has raised US$55m in Series D financing to expand its AI cardiovascular imaging platforms and advance BioIntegrated FFR-CT through FDA clearance. The Boston-based medical technology company said the oversubscribed round brings its total funding to approximately US$185m. The funding will support commercial expansion of Elucid's clinical platforms, further research and development, clinical studies and [...]
A shingles vaccine was linked to lower risks of heart attack, heart failure and stroke in older adults, a US study of 70,000 people suggests. People who received Shingrix had a 12 per cent lower risk of a cardiovascular event during the first three and a half years after vaccination. By the end of the [...]
An AI tool has identified three health paths followed by heart attack survivors, which researchers say could help clinicians tailor care earlier. The study analysed health records from 12,701 UK Biobank participants who had experienced a heart attack and tracked the sequence and timing of new diagnoses over the next five years. Machine learning was [...]
Applications have opened for American Health Association's Health Tech Competition, which will select five finalists working on cardiovascular and brain health technologies. The global competition is seeking market-ready technologies for the prevention, diagnosis and treatment of conditions including high blood pressure, stroke and heart failure. Five finalists will pitch their technologies at Scientific Sessions 2026, [...]
By G2 Speech Ambient speech technology could suit cardiology, where clinicians often handle complex information before, during and after every consultation. By the time a patient arrives at a cardiology clinic, clinicians may already have reviewed their medical history, previous clinic letters, ECGs, echocardiograms and blood test results. Over the next 20 or 30 minutes, [...]
Around 6,600 people in England will gain access to the drug aficamten following simultaneous MHRA authorisation and NICE approval. The once-daily tablet, also known as MYQORZO, is for people with symptomatic obstructive hypertrophic cardiomyopathy. Known as obstructive HCM, the condition causes the heart muscle to become thick and stiff, making it harder to pump blood [...]
